Table 1.
Main characteristics of study participants according to physical frailty and sarcopenia (PF&S) status and gender
| PF&S | NonPF&S | |||||
|---|---|---|---|---|---|---|
| All (n = 100) | Men (n = 25) | Women (n = 75) | All (n = 100) | Men (n = 50) | Women (n = 50) | |
| Age, years | 77.6 ± 5.1* | 79.6 ± 5.5* | 76.9 ± 4.8* | 74.8 ± 3.9 | 75.3 ± 4.0 | 74.4 ± 3.8 |
| BMI, kg/m2 | 30.0 ± 5.0* | 29.3 ± 4.5* | 30.2 ± 5.0* | 27.4 ± 2.9 | 27.1 ± 2.8 | 27.7 ± 3.0 |
| SPPB summary score | 7.2 ± 1.2* | 7.4 ± 1.0* | 7.1 ± 1.3* | 11.4 ± 0.8 | 11.5 ± 0.8 | 11.3 ± 0.8 |
| aLM, kg | 16.2 ± 3.0* | 20.1 ± 2.7* | 14.9 ± 2.0* | 20.1 ± 4.1 | 23.7 ± 2.6 | 16.7 ± 1.6 |
| aLMBMI | 0.54 ± 0.11* | 0.69 ± 0.08* | 0.49 ± 0.08* | 0.76 ± 0.19 | 0.88 ± 0.08 | 0.64 ± 0.20 |
| Number of disease conditions§ | 2.3 ± 1.8 | 2.1 ± 1.9 | 2.5 ± 2.0 | 2.1 ± 1.6 | 2.1 ± 1.6 | 2.0 ± 1.7 |
| Number of medications# | 3.6 ± 2.1 | 3.8 ± 2.2 | 3.5 ± 2.4 | 3.2 ± 2.0 | 3.3 ± 1.9 | 3.1 ± 2.4 |
Data are shown as mean ± standard deviation. *p < 0.05 vs. nonPF&S
§Includes hypertension, coronary artery disease, prior stroke, peripheral vascular disease, diabetes, chronic obstructive pulmonary disease, and osteoarthritis
#Includes prescription and over-the-counter medications
aLM, appendicular lean mass; aLMBMI, appendicular lean mass adjusted by body mass index (BMI); nonPF&S, non-physically frail, non-sarcopenic; SPPB, short physical performance battery